Disparities in prescribing semaglutide and tirzepatide for obesity reveal social factors affecting access and highlight the ...

Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Novo Nordisk partners with telehealth ...

With everything else going on in the world, it can be easy to miss new discoveries in biomedical science. Biomedical research ...

Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least, in one respect. | Novo Nordisk appears to be ...

A grandma of 11 and a New Jersey man have joined the growing chorus of users of the wildly popular weight-loss drugs Ozempic ...

Semaglutide and tirzepatide prescriptions within Epic-affiliated health care systems increased slightly between 2021 and 2024, but ...

The drugmaker is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy ...

Recently, the FDA announced the removal of certain compounded GLP1 ingredients from its drug shortage list. These ingredients ...

Novo Nordisk is partnering with online telehealth companies to sell a direct-to-consumer, lower cost version of its popular weight-loss drug Wegovy. The pharmaceutical company announced it would ...

Novo Nordisk and a popular virtual health company are making Wegovy more accessible to millions of more Americans. Hims & ...

Novo Nordisk said on Tuesday it was partnering with telehealth firms Hims & Hers , Ro and LifeMD to sell branded versions of ...